Aterian Inc (ATER) Stock Price Today
Aura AI Summary
Key Stats
- $13.74MMarket Cap
- -Volume
- Consumer CyclicalSector
- $1.3952W High
- $0.5452W Low
- -Typical Hold Time
- $14.32MEnterprise Value
- -Div Yield
- -Trading Activity
Track Aterian Inc (ATER) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Aterian Inc has traded between a low of $0.54 and a high of $1.39, highlighting its annual price range. Buy and sell Aterian Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Aterian Inc
Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products, and consumer electronics. It has various owned and operated brands include Vremi, Healing Solutions, Xtava, TRUWEO, Spiralize, Pohl+Schmitt, and RIF6. The company generates revenue through the online sales of various consumer products that are sold online.
Most Recent News
Aduro and ECOCE complete Phase 1 of mapping flexible plastic waste in Mexico, starting HCT testing for circular recycling.
Aduro Clean Technologies and ECOCE have successfully completed Phase 1 of mapping flexible and multilayer plastic waste streams in Mexico, estimated at 1.5 million tons annually. The project now moves into testing these materials using Aduro's Hydroc...

Aduro and ECOCE advance to HCT testing for recycling Mexico's flexible plastic waste streams.
Aduro Clean Technologies and ECOCE have completed phase 1 of mapping flexible plastic waste streams in Mexico, estimated at 1.5 million tonnes annually. They are now moving selected post-consumer flexible packaging materials into Hydrochemolytic™ (HC...

FDA accepts resubmission of Camurus' CAM2029 NDA for acromegaly with decision due Dec 18, 2026
Camurus announced that the US FDA has accepted the resubmission of the New Drug Application (NDA) for CAM2029, an extended-release octreotide injection for treating acromegaly. The FDA set a Prescription Drug User Fee Act (PDUFA) target action date o...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.